https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-222007-09-05 00:00:002007-09-05 00:00:00An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Transfusion 2007 Sep;47(9):1588-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Transfusion 2007 Sep;47(9):1588-942007-09-01 00:00:002019-02-15 08:32:34Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Strahlenther Onkol 2007 Sep;183(9):479-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Strahlenther Onkol 2007 Sep;183(9):479-862007-09-01 00:00:002019-02-15 08:35:23Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Liver Int. 2007 Sep;27(7):944-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Liver Int. 2007 Sep;27(7):944-532007-09-01 00:00:002019-02-15 08:37:37Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Int J Hyperthermia 2007 Sep;23(6):513-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Int J Hyperthermia 2007 Sep;23(6):513-272007-09-01 00:00:002019-02-15 08:39:23Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Immunity 2007 Sep;27(3):481-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Immunity 2007 Sep;27(3):481-922007-09-01 00:00:002019-02-15 09:15:08Antigen crosspresentation by human plasmacytoid dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-92007-09-01 00:00:002019-02-15 09:16:56Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-712007-09-01 00:00:002019-02-15 09:16:57Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Cancer Res. 2007 Sep;67(17):8285-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Cancer Res. 2007 Sep;67(17):8285-922007-09-01 00:00:002019-02-15 09:22:08Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / J. Vet. Med. Sci. 2007 Sep;69(9):925-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / J. Vet. Med. Sci. 2007 Sep;69(9):925-302007-09-01 00:00:002019-02-15 09:25:33Comparison of dendritic cell-mediated immune responses among canine malignant cells
